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ABSTRACT
Background Low-dose aspirin reduces cardio-
vascular risk; however, monitoring over-the-coun-
ter medication use relies on the time-consuming
and costly manual review of medical records. Our
objective is to validate natural language processing
(NLP) of the electronic medical record (EMR) for
extracting medication exposure and contraindi-
cation information.
Methods The text of EMRs for 499 patients with
type 2 diabetes was searched usingNLP for evidence
of aspirin use and its contraindications. The results
were compared to a standardised manual records
review.
Results Of the 499 patients, 351 (70%) were using
aspirin and 148 (30%)were not, according tomanual
review. NLP correctly identiﬁed 346 of the 351
aspirin-positive and 134 of the 148 aspirin-negative
patients, indicating a sensitivity of 99% (95% CI
97–100) and speciﬁcity of 91% (95% CI 88–97). Of
the 148 aspirin-negative patients, 66 (45%) had
contraindications and 82 (55%) did not, according
tomanual review.NLP search for contraindications
correctly identiﬁed 61 of the 66 patients with
contraindications and 58 of the 82 patients without,
yielding a sensitivity of 92% (95% CI 84–97) and a
speciﬁcity of 71% (95% CI 60–80).
Conclusions NLP of the EMR is accurate in
ascertaining documented aspirin use and could
potentially be used for epidemiological research as
a source of cardiovascular risk factor information.
Keywords: aspirin, natural language processing
(NLP), quality measurement
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Introduction
Diabetes and heart disease are among the leading
causes of mortality and morbidity in the United
States1 for which a rich set of national quality of care
standards has been developed.2 Included in these
standards are the performance of regular foot exam-
inations, and advising patients on aspirin use and
smoking cessation, all of which are critical to reducing
the risk of severe complications including ulcers,
amputations, myocardial infarctions and heart fail-
ure.3,4 The assessment of these important processes is
a central element in performance measurement and
disease management.5–7
National surveys assessing quality have shown very
low rates of aspirin use in diabetes patients at high risk,
resulting in a lost opportunity to reduce cardiovascu-
lar morbidity and mortality at low cost.8,9 Generally,
performance measures have most often been assessed
by using manual charting. However, this manual
process is expensive and subject to lack of internal
consistency with poor interrater reliability.10–13 With
increasing adoption of the EMR14 healthcare pro-
viders have turned to structured data within the EMR
in order to expedite clinical performance measure-
ment. However, for certain measures (e.g. prescribing
medications for speciﬁc indications), methods based
on structured EMRs are of questionable validity com-
pared to the information reported in the unstructured,
free-text part of the EMR.15 In addition, methods
based on automatic examination of the structured
part of the EMR for medication prescription are
limited in their ability to capture the situations where
there are legitimate reasons (e.g. contraindications)
for not prescribing a medication otherwise required
by the treatment guidelines.15 The information neces-
sary for a comprehensive and accurate assessment of
compliance with quality and safety measures is
contained in the unstructured text part of the EMR
and requires specialised tools for its extraction and
aggregation. In the context of the EMR, natural
language processing (NLP) oﬀers a promisingmethod
of automating the collection of a rich set of infor-
mation for quality improvement and safety that would
otherwise require manual chart abstraction.16–23 In
the contextofmedicationuse andpharmaco-surveillance,
a number of signiﬁcant advances have been made in
automatic identiﬁcation of disease–drug associations,24
structured medication event information in discharge
summaries25 and other types of textual clinical reports.26
The main objective of this study was to determine the
validity of NLP for identiﬁcation from the EMR of
documentation indicative of aspirin use and potential
contraindications for its use.
Methods
Participants
Eligible patients were 1) seen in one of six primary care
practices at the Mayo Clinic; 2) participated in an
employer-funded health plan; 3) had the diagnosis of
diabetes prior to 1999, and 4) had given prior research
authorisation. The Mayo Clinic is a large academic
medical centre in Rochester, Olmsted County,
Minnesota, USA which provides primary care to local
residents, including over 6000 patients with dia-
betes.27
Clinical reports
Mayo Clinic physicians have been documenting patient
encounters electronically since 1994. Currently, clini-
cal notes are dictated and stored in electronic format –
theMayoClinic EMR. This comprises a dataset of over
25million inpatient and outpatient notes. These notes
are in compliance with the American National Stan-
dards InstituteClinicalDocumentArchitecture, awidely
accepted standard for clinical documentation.28 All
clinical notes (12 563 for the year 2006) were available
for analysis for all but four of 519 eligible patients
(ﬁnal study population 515).
Reference standards
We compiled three reference standards in stages – one
for aspirin exposure, one for cardiovascular vs non-
cardiovascular use and one for contraindications to
aspirin use. All three reference standards were obtained
by manual review of clinical notes dictated in the year
2006 for the participants in the study. The records of
all 515 participants were examined to determine if the
record contained evidence that the participant was
using aspirin. The reference standard for cardiovascu-
lar use was obtained by manual examination of the
records of those participants for whom there was
evidence of aspirin use. Finally, the reference standard
for contraindications was obtained by examining only
the records that did not contain evidence of aspirin
use. Manual examination was performed by a stand-
ardised records reviewer (SB). Interrater agreement
was determined on a random sample of 50 medical
records independently reviewed by two reviewers (SB
and PH), with disagreements subsequently resolved
by one of the study investigators (NS). We used the
National Guideline Clearinghousea as a standard for
awww.guideline.gov/summary/summary.aspx?ss=15&doc_
id=10843&string=5658
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contraindications to aspirin use. These criteria included
allergy to aspirin, certain gastrointestinal disorders
(e.g. peptic ulcer, bleeding), intracranial bleeding,
uncontrolled hypertension and anticoagulant and
non-steroidal anti-inﬂammatory drug (NSAID) ther-
apy. A list of NSAIDs was compiled, using the Federal
Drug Administration (FDA)b for prescription and the
American College of Gastroenterologyc for non-pre-
scription preparations.
Automatic text search
The clinical notes for each patient were searched
electronically using a list of key terms representative
of generic and brand names for aspirin, dosage infor-
mation and contraindications. The details of the term
lists and the actual algorithm implemented in the Perl
programming language are shown in the Appendix
and are also available from the corresponding author
on request. The algorithms for text processing and the
content of the electronic queries were developed solely
on the basis of the guidelines that were used for
manual classiﬁcation of the records. No text of the
clinical notes was used to deﬁne the queries or to
design the algorithms. Furthermore, the investigator
who did the programming was blinded to the manual
classiﬁcation, while the investigator who did themanual
classiﬁcation and created the reference standard was
blinded to the algorithm design and implementation.
Statistical analysis
Sensitivity and speciﬁcity, standard operating charac-
teristics for binary classiﬁcation tasks, were used to
assess the accuracy of the automated algorithms.
Sensitivity is the ratio of correctly classiﬁed positive
examples to the total number of positive examples
in the reference standard. Speciﬁcity is the ratio of
correctly classiﬁed negative examples to the total
number of negative examples in the reference stan-
dard. A 95% conﬁdence interval was calculated for
each estimate based on binomial error distribution.
Kappa statistic was used to account for random eﬀects
in estimating the interrater agreement.29
Results
Manual classiﬁcation
Aspirin exposure
Of the 515 participants’ records in this study, evidence
of aspirin use was unknown for 16 (2%) due to
absence of clinical notes for these patients in year
2006. Excluding these participants from further analy-
sis, 351 (70%) of the remaining 499 participants were
identiﬁed as having evidence of aspirin use, while 148
(31%) did not have such evidence. Patients on aspirin
were more likely to be male (p=0.0027) and elderly
(mean age: 58.8 vs 53.2, p<0.0001).
Cardiovascular use
Of the 351 participants with evidence of aspirin use
in their record, only 4 (1%) used aspirin for non-
cardiovascular purposes (e.g. pain management).
Contraindications
Of the 148 participants without evidence of aspirin use
in their records, 82 (55%) had no contraindications.
Of the remaining 66 (45%) participants with contra-
indications, 40 (26%) were using NSAIDs, 13 (9%)
were on Coumadin, three (2%) on Plavix, one had a
diagnosis of peptic ulcer, one had a history of intra-
cranial bleeding, two had a history of gastro-intestinal
bleeding, twowere noted as allergic to aspirin and four
had notes in their record advising against the use of
NSAIDs for other reasons. The latter category included
one participant with a note stating ‘history of papillary
necrosis from NSAIDs’, one with ‘NSAID induced
gastritis’, one with ‘chronic renal insuﬃciency – patient
cannot use NSAIDs including aspirin’ and one with
‘chronic renal disease – patient advised to stop taking
aspirin’.
Interrater reliability
The random sample of 50medical records reviewed by
two reviewers contained 500 observations. The
interrater agreement measured by the Kappa statistic
was 0.93 (95%CI0.86–1.00).Of the50 records reviewed,
a total of ten had at least one instance of aspirin
mention on which the reviewers disagreed. The dis-
agreements were resolved by a study investigator (NS)
and the corrected classiﬁcations for these ten patients
were used in the reference standard.
Compliance with aspirin use guidelines
Having 351 participants identiﬁed as using aspirin and
66 identiﬁed as having contraindications results in 417
bwww.fda.gov/CDER/Drug/infopage/COX2/
NSAIDmedguide.pdf
cwww.gi.org/patients/women/asprin.asp
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out of 499 people (84%). This demonstrates a high
level of compliance with guidelines for aspirin and
contraindications for its use in this population. A stand-
ard chart audit that does not take contraindications
into account would have resulted in identifying 351
out of 499 (70%) people, showing a 14% lower level of
compliance.
Automatic text search
Automatic classiﬁcation of medical records with NLP
compared to the manual reference standard had a
sensitivity of 99% (95% CI 97–100; see Table 1). Five
records were misclassiﬁed as having evidence of aspirin
use while no such evidence was found during manual
abstraction. Fourteen records were misclassiﬁed as con-
taining no evidence of aspirin use resulting in a
speciﬁcity of 92% (95% CI 88–97).
Identiﬁcation of CV use
All four of the four records with evidence of non-
cardiovascular use of aspirin were correctly identiﬁed
(sensitivity of 100% (95% CI 55–100) ); however, the
algorithm also produced six false positives resulting in
the speciﬁcity of 98% (95% CI 96–99).
Identiﬁcation of contraindications
NLP correctly identiﬁed 61 out of 66 records with one
or more potential contraindications to aspirin use
resulting in a sensitivity of 92% (95% CI 84–97). Of
the 82 records with no apparent contraindications,
58 were identiﬁed correctly by the automated system
resulting in the speciﬁcity of 71% (95% CI 60–80).
We also applied theNLPmechanism for identifying
contraindications to the 351 records that were manu-
ally classiﬁed as being on aspirin to ﬁnd that 175, or
49% (95% CI 44–54), of these contained one or more
mentions of a potential contraindication. Further man-
ual analysis performed by one of the study investi-
gators (SS) showed that 164 (94%, 95% CI 90–97) of
the 175 patients indeed had at least one potentially
relevant contraindication including 24 (14%) patients
on Coumadin, 19 (11%) on Plavix, 65 (37%) on an as-
needed dose of an NSAID, 65 (37%) on a regular dose
of NSAID, 13 (7%) with a history of gastrointestinal
bleeding and three (2%) with another comorbidity
(e.g. renal failure, hypertension). At least half of these
164 patients had two or more (up to ﬁve) potential
contraindications.
Compliance with aspirin use guidelines
The correct identiﬁcation by the NLP of 346 partici-
pants as using aspirin and 61 identiﬁed as having
contraindications results in 405 out of 499 people
(81%), a similar compliance to the manually deter-
mined level of 84%.
Discussion
We demonstrated that automated NLP methodology
for searching the text of the EMR has the potential to
oﬀer highly accurate results not only in identifying
whether the patient record contains evidence of as-
pirin use, but whether such use is for cardiovascular or
non-cardiovascular purposes and whether the record
contains evidence of potential contraindications to
Table 1 Sensitivity and speciﬁcity of the automatic text classiﬁer as compared to a manual
reference standard
Reference standard
Positive Negative Sensitivity Speciﬁcity PPV NPV
n correct n
total
n correct n
total
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
On aspirin 346 351 134 148 99
(97–100)
91
(88–97)
96
(94–98)
96
(93–99)
CV use 4 4 341 347 100
(55–100)
98
(97–99)
40
(14–73)
100
(98–100)
Contraindications 61 66 58 82 92 (84–97) 71 (60–80) 71 (60–80) 92 (83–97)
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aspirin use. These ﬁndings demonstrate that the text
of the EMR provides a valuable source of information
on documentation of medication exposure, particu-
larly for over-the-counter medications for which no
other documentation exists either in the pharmacy or
in administrative claims databases. Our ﬁndings indi-
cate that the automated text processing methodology is
as good asmanual audit (with only a 3%diﬀerence) in
determining the level of compliance with guidelines
for aspirin use. A standard manual chart audit would
have yielded a lower compliance level, underestimating
the true quality of care delivery and at the same time
involving much more eﬀort and cost. Thus our meth-
odology can be considered another strategy to add to
the toolbox for quality improvement.
Similar to our study, previous reports using NLP
methodology to detect reliable identiﬁcation of evi-
dence for foot examinations28 and tobacco cessation
counselling29 from the text of clinical reports23 dem-
onstrate the increasing value of EMRs as an alternative
to manual records review for diﬃcult to measure data
elements required for continuous quality improve-
ment and reporting. Persell et al15 have demonstrated
the value of using the text of clinical notes in reporting
on ACE-inhibitor prescribing for patients with heart
failure. Similarly, our study provides additional evi-
dence pointing in the same direction, where almost
half (45%) of the people with type 2 diabetes who are
not using aspirin have documented potential contra-
indications.
Our current ﬁndings also demonstrate that NLP
can be used for reliable ascertainment of contraindi-
cations for aspirin use. Our automatedNLP algorithm
identiﬁed at least one contraindication for 49% of
people on aspirin with half of these people having two
or more contraindications. Clearly, these results are
indicative rather than conclusive because therapeutic
decisions are made based on the values and prefer-
ences of individual patients guided by their provider.
However, dissemination of NLP-derived reports that
include potential contraindications may help encour-
age patient–provider communication, elucidate poten-
tial safety concerns and facilitate risk management for
an individual patient.
While it is unlikely that local and national bench-
marking organisations will immediately adopt NLP as
a technique for documentation of quality measures,
nevertheless it is eﬃcient and scalable and can easily
provide immediate value for internal reporting of
quality and safety metrics by a health system. While
the NLP system for determining potential contraindi-
cations for aspirin use is highly sensitive (61 of 66
records) it is less speciﬁc (24 of 82 records were false
positives). However, even if all 85 (61 plus 24) records
automatically classiﬁed as having potential contra-
indications required veriﬁcation by the patient or the
healthcare team, this would constitute only 16%of the
entire volume of 499 records. Thus our methodology
could be used for a dramatic reduction of the work-
load, making quality assurance and safety monitoring
at the individual patient level much more feasible.
Error analysis
To gain a better understanding of the generalisability
of our approach, we conducted an informal error
analysis by manually examining the records of mis-
classiﬁed patients in each of the three categories:
aspirin use, cardiovascular use and contraindications.
Of the ﬁve records that were manually determined to
have evidence of aspirin use and were misclassiﬁed by
the automated classiﬁer (false negatives), one instance
was due to a manual abstraction error, one was due to
a misspelling of aspirin as ‘asprin’ and three were due
to formatting unanticipated by the algorithm used
to query the text. Of the 11 records labelled by the
automatic classiﬁer as containing evidence of aspirin
use but manually classiﬁed as not containing such
evidence (false positives), six were due to an error in
manual abstraction and the rest were due to a failure in
the identiﬁcation of cues indicative of aspirinmention
in a probable or negated context (e.g. ‘Will continue
on Plavix as patient’s preference rather than aspirin’).
The examination of misclassiﬁcation errors in car-
diovascular vs non-cardiovascular use revealed that
ﬁve of the six false positives were due to a manual
abstraction error. The latter resulted from examining
records with large numbers of notes with predom-
inantly cardiovascular use of aspirin but with one or
two notes mentioning additional use of aspirin for
pain management. One of the six false positives was
truly ambiguous: ‘I recommended to continue Ecotrin
daily aspirin and discontinue all other Bayer prn
products’. In this example, both daily and pro re nata
(as needed) usages of aspirin are mentioned in the same
sentence.
Analysis of the errors resulting from automatic
identiﬁcation of contraindications showed that three
of the ﬁve false negatives were due to a manual
abstraction error. For example, one of the records
wasmanually classiﬁed as having a diagnosis of gastro-
intestinal bleeding in one of the notes; however, upon
second examination of this patient’s record, amention
of abdominal wall cellulitis and a ruling out of gastro-
intestinal bleeding were found in a subsequent note.
The other two false negatives were due to reasons for
non-use of aspirin other than potential contraindi-
cations established by the national standards. For
example, one of the records referred to NSAID induced
gastritis and the other to renal insuﬃciency as reasons
why the treating physician recommended that aspirin
should not be used. These examples are rare in our
dataset. Overall, our automated NLPmethod is highly
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eﬀective in identifying common contraindications.
The examination of the 18 false positives showed that
four were due to manual abstraction error, eight were
due to a mention of an over-the-counter NSAID in an
‘as needed’ context and six were due to a failure by the
regular expression mechanism to identify negation
(e.g. ‘He remains oﬀ aspirin and NSAID therapy’).
Limitations and strengths
Several limitations must be mentioned to facilitate
interpretation of the results. First, the text of the EMR
can be used only as a surrogate to identify patient
exposure to over-the-counter medications. Arguably,
medication reconciliation may be a more complete
way to ascertain medication exposure; however, known
concerns exist with using patient self-report for medi-
cation information due to imperfect recall, particu-
larly for over-the-counter medications. Ideally, a
variety of information sources including patient self-
report, pharmacy transaction records and the text of
the EMR should be used to create an accurate rep-
resentation of over-the-counter medication use by
patients. Second, consistent with national and re-
gional quality reporting and benchmarking eﬀorts
and for the sake of feasibility, we limited the manual
examination of the text of clinical reports to a single
year. While the Mayo Clinic EMR tends to have
continuity where important facts from previous visits
typically carry over into the documentation of the
subsequent visit, this may not be the case with other
EMR systems, limiting the generalisability of our
ﬁndings. This is particularly true of information on
contraindications where, for example, a history of
intracranial bleeding may date back several years.
For continuous EMRs, the scalability of the technique
we have described oﬀers a distinct advantage for
analysing longitudinal data on large number of patients.
Going forward, it will be important to demonstrate
the generalisability of the methodology described in
this paper to EMR systems other than the one used at
the Mayo Clinic.
Our study also has a number of unique strengths.
The sample size used for testing the methodology
is large (n=499 records with 12 563 notes) relative to
other studies of automated text processing methods.
While using enrollees in an employer-funded health
plan limits the generalisability of our ﬁndings, it is also
a strength as this population receives its care primarily
at a single institution and thus represents the model
scenario in terms of homogeneity and completeness of
themedical records. Finally, theMayo Clinic EMR is a
state of the art system that is fully compliant with
national standards for clinical documentation (HL7
CDA) that have also been adopted by most major
EMR vendors in the USA.
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Appendix
Figure 1 Perl regular expressions deﬁnitions
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Figure 2 Pseudo-code illustrating the search algorithm based on regular expressions

